Cantharidin solution (0.7%) drug-device combination and its use in molluscum contagiosum: James Del Rosso

Dr. James Del Rosso (JDR Dermatology Research, Las Vegas, Nevada, USA, and President-Elect American Acne & Rosacea Society) discusses the efficacy and safety results from the CAMP-1 and CAMP-2 studies, highlighting their role in supporting the recent FDA approval cantharidin solution (0.7%) for treatment of molluscum contagiosum. He also examines who benefits most from the […]

Molluscum contagiosum, a common skin infection caused by a poxvirus (molluscum contagiosum virus), usually resulting in benign, mild skin disease characterized by lesions appearing anywhere on the body. In this interview, Dr. James Del Rosso (JDR Dermatology Research, Las Vegas, Nevada, USA, and President-Elect American Acne & Rosacea Society) shares insights into molluscum contagiosum, and […]

Dermatology and sexual health raise critical topics such as dermatological manifestations linked to STIs e.g. monkeypox and cutaneous syphilis, the effectiveness of vaccination, and the rise in antibiotic resistance to treat cutaneous STIs.  touchDERMATOLOGY were delighted to speak with Dr Georg Stary (Department of Dermatology, Medical University of Vienna, Vienna, Austria) at EADV 2023 to explore present challenges and future directions in addressing these complex and pressing issues. The abstract ‘Vaccination in STIs: What is the current state?’ (Presentation ID PLB-02) and ‘Antibiotic landscape in genital ulcers’ (Presentation ID D2T12.3B) was presented at EADV 2023, Berlin, 11-14 October 2023 #EADVCongress. Questions What dermatological manifestations are associated with STIs? How effective are existing vaccines for STIs, and how have recent developments in vaccinations influenced their development? What do you see as the future directions of STI vaccination? What is the present status of antibiotic resistance in STIs? What challenges do healthcare professionals face in selecting appropriate antibiotics for STIs, given the changing microbial landscape? How could a multifaceted approach impact the prevention of antimicrobial resistant STIs? Disclosures: Georg Stary has nothing to disclose in relation to this video interview. Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones and Katey Gabrysch. Filmed in coverage of the EADV Annual Meeting This content was developed by Touch Medical Media and is not affiliated with the  European Academy of Dermatology & Venereology  (EADV) or the congress.